Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Patterson Companies, Inc. (NASDAQ:PDCO)

• Dividend Yield: 4.93%
• Baird analyst Jeff Johnson maintained a Neutral rating and cut the price target from $30 to $28 on Aug. 29. This analyst has an accuracy rate of 78%.
• Evercore ISI Group analyst Ross Muken maintained an In-Line rating and lowered the price target from $25 to $23 on Aug. 29. This analyst has an accuracy rate of 65%.
• Recent News: On Aug. 28, Patterson Companies reported worse-than-expected first-quarter adjusted EPS and sales.
• Benzinga Pro's real-time newsfeed alerted to latest PDCO news.

Johnson & Johnson (NYSE:JNJ)

• Dividend Yield: 3.01%
• Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on Sept. 3. This analyst has an accuracy rate of 72%.
• Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $167 to $169 on July 18. This analyst has an accuracy rate of 72%.
• Recent News: Johnson & Johnson will host a conference call on Tuesday, Oct. 15th to review third-quarter results.
• Benzinga Pro’s charting tool helped identify the trend in JNJ stock.

CVS Health Corporation (NYSE:CVS)

• Dividend Yield: 4.58%
• RBC Capital analyst Ben Hendrix reiterated an Outperform rating with a price target of $68 on Sept. 4. This analyst has an accuracy rate of 76%.
• Barclays analyst Andrew Mok maintained an Equal-Weight rating and cut the price target from $65 to $63 on Aug. 8. This analyst has an accuracy rate of 74%.
• Recent News: On Aug. 14, CVS Health named Heidi Capozzi Executive Vice President, Chief People Officer.
• Benzinga Pro’s signals feature notified of a potential breakout in CVS shares.

Read More:

• Jim Cramer: Oklo Is Losing Money ‘Hand-Over-Fist,’ But This Private Equity Stock Is A Buy